Last update :
18/04/2024
References   References 1514  
Type : Manufacturer

Research teams :
Authors :
Title : Verteporfin (Visudyne®) – Summary of Product Characteristics
Reference : Novartis Pharmaceuticals UK Ltd 2015

Level of Evidence : 
Manufacturer's stability data
Physical stability : 
Chemical stability : 
Other methods : 
Comments : 

List of drugs
InjectionVerteporfine Anticancer drug
Factors which affect stability Solvent Sodium chloride 0,9% Induces Precipitation
Stability in solutions Glass Water for Injection 2 mg/ml 25°C Protect from light
4 Hour
Stability in solutions Not specified Glucose 5% 0,3-0,4 mg/ml 25°C Protect from light
4 Hour
Incompatible + Sodium chloride 0,9%

  Mentions Légales